23andMe

  • The New York Times and 23andMe Disagree

    Feb 14

    The Editorial Board of The New York Times posted an opinion piece titled: “Why You Should Be Careful About 23andMe's Health Test”. In response, 23andMe posted a letter to the editor titled: “23andMe Responds: Empowering Consumers”. The two disagree about the accuracy of 23andMe's genetic tests results. The New York Times Editorial Board...

    More

  • 23andMe Explains Why Diversity Matters in Genetic Research

    Feb 5

    23andMe posted an informative blog that explains why diversity matters in research. Improving diversity and inclusion of underrepresented populations in research doesn't just benefit those groups. It benefits everyone. Africans and African Americans are among the most underrepresented populations in genetic health research, yet they face the mos...

    More

  • Study: Genetics May Nudge Some People Toward Risky Behavior

    Jan 15

    A study done by researchers from the Social Science Genetic Association Consortium (SSGAC) suggests that genetics may nudge some individuals toward more risky behavior like smoking, drinking and speeding. The study, which was published in the journal Nature Genetics, included data from more than a million people. The researchers identified 124 g...

    More

  • 23andMe Works Toward Improving Diversity in Genetic Research

    Dec 5

    23andMe has put in effort toward improving diversity in its genetic research. This includes their Global Genetics Project and their Populations Collaborations Program. The goal is not only to help diversify 23andMe's research database, but also to drive inclusion of understudied populations. 23andMe points out that currently, more than 90 percen...

    More

  • 23andMe Provides Information About Breast Cancer Genes

    Oct 11

    October is Breast Cancer Awareness Month. Certain types of breast cancer can run in families. 23andMe offers the first and only FDA-authorized, direct-to-consumer BRCA genetic health risk report. This test focuses on three specific variants of the BRCA1 and BRCA2 genes. 23andMe offers a genetic test for three variants of the BRCA1 and BRCA2 gen...

    More

  • Which DNA Company Gives You a Bigger Bang for the Buck?

    Aug 21

    Genealogists who have decided to explore the information that is hidden in their genes face a dilemma. Which DNA testing company should they choose? Which one can give them a bigger bang for the buck? It all depends on what you are hoping to learn from your DNA results. Here are a few to consider: AncestryDNA * Regular Price: $99 * More tha...

    More

  • 23andMe Adds Four New Trait Reports

    Jul 9

    23andMe announced that they have added four new trait reports to its growing list of more than two-dozen trait reports. The new trait reports are the latest in a series of new offerings for 23andMe customers interested in exploring their genetics in a fun way. 23andMe points out that results from 23andMe research are preliminary and are meant fo...

    More

  • MyHeritage and 23andMe to Donate DNA Kits to Reunite Families

    Jul 2

    Two of the companies that make direct-to-consumer DNA test kits are offering free DNA tests to help reunite families that were separated from each other at the United States border. Both MyHeritage and 23andMe have started contacting relevant government agencies and non-profit legal aid organizations that are representing the families. Genealog...

    More

  • 23andMe has Genetic Risk Report for G6PD Deficiency

    Jun 13

    23andMe announced that it has added a new Genetic Risk Report for G6PD Deficiency. It looks for one genetic variant linked to episodes of anemia. G6PD stands for “Glucose-6 phosphate dehydrogenase deficiency”. It is a genetic disorder that occurs almost exclusively in males. It affects red blood cells, which carry oxygen from the lungs to ti...

    More

  • Study Offers Look at Genetics and Nearsightedness

    Jun 5

    Have you ever wondered why some of the people in your family are nearsighted? 23andMe pointed out a new study by a consortium of researchers that offers the most detailed view yet of the role of genetics and nearsightedness. The 23andMe Research Team was among the consortium of researchers involved in the study. The study is titled: “Genome-wi...

    More